← Open Payments lookup

XIAOHONG JIANG: Open Payments

NPI 1063137263 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,307 in 34 payments from 13 companies in 2025. Trend: 2023 $633 · 2024 $1,577 · 2025 $1,307

Food & beverage: $908Long term medical supply or device loan: $399
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation6$451
Daiichi Sankyo Inc.10$289
AstraZeneca Pharmaceuticals LP3$154
Takeda Pharmaceuticals U.S.A., Inc.3$83
Janssen Biotech, Inc.2$76
E.R. Squibb & Sons, L.L.C.2$51
Caris MPI, Inc.2$37
Exelixis Inc.1$32
GlaxoSmithKline, LLC.1$30
Boehringer Ingelheim Pharmaceuticals, Inc.1$30

Products named: KISQALI, Enhertu, CALQUENCE, FRUZAQLA, Vanflyta, SCEMBLIX, OPDIVO, TECVAYLI.

Industry payments across MD — which companies pay providers there.